Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovaBay Pharmaceuticals (NBY) Asset Utilization Ratio (2016 - 2025)

NovaBay Pharmaceuticals (NBY) has disclosed Asset Utilization Ratio for 15 consecutive years, with 0.54 as the latest value for Q3 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 70.23% to 0.54 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.54, a 70.23% decrease, with the full-year FY2024 number at 1.57, up 91.0% from a year prior.
  • Asset Utilization Ratio was 0.54 for Q3 2025 at NovaBay Pharmaceuticals, up from 0.28 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 2.24 in Q2 2024 to a low of 0.28 in Q2 2025.
  • A 5-year average of 0.93 and a median of 0.74 in 2022 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: soared 174.04% in 2024, then crashed 87.72% in 2025.
  • NovaBay Pharmaceuticals' Asset Utilization Ratio stood at 0.59 in 2021, then increased by 26.58% to 0.74 in 2022, then increased by 29.15% to 0.96 in 2023, then surged by 109.58% to 2.01 in 2024, then plummeted by 72.93% to 0.54 in 2025.
  • Per Business Quant, the three most recent readings for NBY's Asset Utilization Ratio are 0.54 (Q3 2025), 0.28 (Q2 2025), and 0.83 (Q1 2025).